232 related articles for article (PubMed ID: 37049981)
21. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.
Chan EWL; Yee ZY; Raja I; Yap JKY
J Glob Antimicrob Resist; 2017 Sep; 10():70-74. PubMed ID: 28673701
[TBL] [Abstract][Full Text] [Related]
22.
Barman TK; Kumar M; Mathur T; Namba E; Singh D; Chaira T; Kurosaka Y; Yamada M; Upadhyay DJ; Masuda N
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610202
[TBL] [Abstract][Full Text] [Related]
23. A highly substituted and fluorescent aromatic-fused imidazole derivative that shows enhanced antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
Bulut O; Oktem HA; Yilmaz MD
J Hazard Mater; 2020 Nov; 399():122902. PubMed ID: 32512278
[TBL] [Abstract][Full Text] [Related]
24. Antibacterial activity evaluation of vinyl sulfones against global predominant methicillin-resistant Staphylococcus aureus USA300.
Vorasin O; Momphanao K; Katrun P; Kuhakarn C; Jiarpinitnun C
Bioorg Med Chem Lett; 2022 May; 63():128652. PubMed ID: 35245662
[TBL] [Abstract][Full Text] [Related]
25. Antibacterial activity of THAM Trisphenylguanide against methicillin-resistant Staphylococcus aureus.
Weaver AJ; Shepard JB; Wilkinson RA; Watkins RL; Walton SK; Radke AR; Wright TJ; Awel MB; Cooper C; Erikson E; Labib ME; Voyich JM; Teintze M
PLoS One; 2014; 9(5):e97742. PubMed ID: 24840307
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
MacGowan AP; Noel AR; Tomaselli S; Bowker KE
Antimicrob Agents Chemother; 2013 Jun; 57(6):2451-6. PubMed ID: 23459495
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
MacGowan AP; Noel AR; Tomaselli S; Elliott HC; Bowker KE
Antimicrob Agents Chemother; 2011 Feb; 55(2):867-73. PubMed ID: 21078943
[TBL] [Abstract][Full Text] [Related]
28. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and In Vitro Antimicrobial SAR of Benzyl and Phenyl Guanidine and Aminoguanidine Hydrazone Derivatives.
Dohle W; Su X; Nigam Y; Dudley E; Potter BVL
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615201
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of novel pleuromutilin derivatives containing benzimidazoles as effective anti-MRSA agents.
Zhang QW; Ren J; Lu JX; Chen XY; He XJ; Wang Q; Zhou ZD; Jin Z; Zeng ZL; Tang YZ
Drug Dev Res; 2023 Nov; 84(7):1437-1452. PubMed ID: 37534779
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods.
Baldoni D; Steinhuber A; Zimmerli W; Trampuz A
Antimicrob Agents Chemother; 2010 Jan; 54(1):157-63. PubMed ID: 19805560
[TBL] [Abstract][Full Text] [Related]
32. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial activity of 2-hydroxy-4-methoxybenzaldehyde and its possible mechanism against Staphylococcus aureus.
Kannappan A; Jothi R; Tian X; Pandian SK; Gowrishankar S; Chunlei S
J Appl Microbiol; 2023 Jul; 134(7):. PubMed ID: 37422440
[TBL] [Abstract][Full Text] [Related]
35. Anti-hepatitis C virus drug simeprevir: a promising antimicrobial agent against MRSA.
Li Y; She P; Xu L; Liu Y; Liu S; Li Z; Yang Y; Li L; Hussain Z; Wu Y
Appl Microbiol Biotechnol; 2022 Apr; 106(7):2689-2702. PubMed ID: 35338386
[TBL] [Abstract][Full Text] [Related]
36. Synergistic antibacterial effect of apigenin with β-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant Staphylococcus aureus.
Akilandeswari K; Ruckmani K
Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):74-82. PubMed ID: 28145860
[TBL] [Abstract][Full Text] [Related]
37. Preparation and optimization of ciprofloxacin encapsulated niosomes: A new approach for enhanced antibacterial activity, biofilm inhibition and reduced antibiotic resistance in ciprofloxacin-resistant methicillin-resistance Staphylococcus aureus.
Mirzaie A; Peirovi N; Akbarzadeh I; Moghtaderi M; Heidari F; Yeganeh FE; Noorbazargan H; Mirzazadeh S; Bakhtiari R
Bioorg Chem; 2020 Oct; 103():104231. PubMed ID: 32882442
[TBL] [Abstract][Full Text] [Related]
38. Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.
Karlowsky JA; Nichol K; Zhanel GG
Clin Infect Dis; 2015 Sep; 61 Suppl 2():S58-68. PubMed ID: 26316559
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial activity and synergistic antibiotic mechanism of trialdehyde phloroglucinol against methicillin-resistant Staphylococcus aureus.
Shen D; Duan S; Hu Y; Liang J; Tang Y
Phytother Res; 2023 Feb; 37(2):490-504. PubMed ID: 36161387
[TBL] [Abstract][Full Text] [Related]
40. A 3-alkylpyridine-bearing alkaloid exhibits potent antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) with no detectable resistance.
Herrera KMS; Lopes GFM; Oliveira ME; Sousa JF; Lima WG; Silva FK; Brito JCM; Gomes AJPS; Viana GHR; Soares AC; Ferreira JMS
Microbiol Res; 2022 Aug; 261():127073. PubMed ID: 35636092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
